Stay updated on Pimavanserin Safety in Neurodegenerative Disease Clinical Trial
Sign up to get notified when there's something new on the Pimavanserin Safety in Neurodegenerative Disease Clinical Trial page.

Latest updates to the Pimavanserin Safety in Neurodegenerative Disease Clinical Trial page
- Check5 days agoChange DetectedA banner announces NIH’s website transition and says federal agencies are using “Super Intelligence” instead of “Artificial Intelligence” under Executive Order 14434. It is separate from the study information.SummaryDifference0.5%

- Check12 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check19 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check40 days agoChange DetectedThe study history now shows a new Revision: v3.7.0 entry, reflecting an updated version of the record. The earlier Revision: v3.6.6 entry has been removed from the visible history.SummaryDifference0.1%

- Check61 days agoChange DetectedA new revision entry for the page history (v3.6.6) was added, and the previous revision (v3.6.5) was removed, reflecting a maintenance update to the record's metadata.SummaryDifference0.1%

- Check82 days agoChange DetectedThe study record history now includes a new revision entry labeled v3.6.5, replacing the previous v3.6.4 entry as part of an incremental update to the page's version history.SummaryDifference0.1%

Stay in the know with updates to Pimavanserin Safety in Neurodegenerative Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pimavanserin Safety in Neurodegenerative Disease Clinical Trial page.